Lam T, Hayman J, Berecki-Gisolf J, Sanfilippo P, Lubman DI, Nielsen S. Pharmaceutical opioid poisonings in Victoria, Australia: rates and characteristics of a decade of Emergency Department presentations across nine pharmaceutical opioids [published online ahead of print, 2021 Aug 2]. Addiction. 2021;10.1111/add.15653. doi:10.1111/add.15653
Pub Category: Abuse, Misuse, Diversion
Green JL, Robbins RS, Dailey-Govoni T, Butler SF. Nonmedical Use of Xtampza® ER and Other Oxycodone Medications in Adults Evaluated for Substance Abuse Treatment: Real-World Data from the Addiction Severity Index-Multimedia Version (ASI-MV®). J Pain Res. 2021;14:1773-1783. Published 2021 Jun 15. doi:10.2147/JPR.S304805
Dart RC, Iwanicki JL, Black J, Olsen H, Severtson G. Measuring Prescription Opioid Misuse and Its Consequences [published online ahead of print, 2021 Feb 19]. Br J Clin Pharmacol. 2021;10.1111/bcp.14791. doi:10.1111/bcp.14791
Rzetelny A, Meske D, Patel P, Passik S. Tapentadol is the least common opioid found in admission urine drug-test results at an intensive outpatient opioid-use disorder treatment program in Ohio: A brief report. J Opioid Manag. 2021;17(1):13-17. doi:10.5055/jom.2021.0610
Geoffrey Severtson S, Kreider SED, Amioka EC, Margolin ZR, Iwanicki JL, Dart RC. Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER. Pain Med. 2020;21(12):3660-3668. doi:10.1093/pm/pnaa272
Basu D, Mahintamini T, Ghosh A, et al. Tapentadol, the new kid on the block in India: Is it time to worry?. Indian J Psychiatry. 2020;62(6):697-702. doi:10.4103/psychiatry.IndianJPsychiatry_332_20
Vosburg SK, Beaumont J, Dailey-Govoni ST, Butler SF, Green JL. Evaluation of Abuse and Route of Administration of Extended-Release Tapentadol Among Treatment-Seeking Individuals, as Captured by the Addiction Severity Index-Multimedia Version (ASI-MV). Pain Med. 2020;21(9):1891-1901. doi:10.1093/pm/pnz250
Mukherjee D, Shukla L, Saha P, et al. Tapentadol abuse and dependence in India. Asian J Psychiatr. 2020;49:101978. doi:10.1016/j.ajp.2020.101978
Ansley BS, Sethi R. Tapentadol: An Opioid of Abuse Acquired Online. Prim Care Companion CNS Disord. 2020;22(1):19l02432. Published 2020 Feb 20. doi:10.4088/PCC.19l02432
Peacock A, Gisev N, Memedovic S, et al. Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study. Drug Alcohol Depend. 2020;206:107697. doi:10.1016/j.drugalcdep.2019.107697